Convergent Therapeutics last raised $22.2M in its Early Stage VC (Jul 2024).
- ·Watch Convergent Therapeutics: the Monday email on marks, rounds and moves
Convergent Therapeutics funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jul 2024 | Early Stage VC | $22.2M | ▮ | ▮ |
| May 2023 | Early Stage VC (Series A) | $90.0M | ▮ | ▮ |
Membership and data by Private Market View
Convergent Therapeutics valuation
Convergent Therapeutics's last known valuation is $280 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
How much has Convergent Therapeutics raised?
Convergent Therapeutics has raised $130 million across 2 recorded rounds since 2023. The largest was a $90 million Series A in May 2023; the most recent was a $22.2 million early-stage round in Jul 2024.
Convergent Therapeutics has filed 2 Form Ds with the SEC since 2023, most recently in Aug 2024 ($22.2 million sold to 1 investor).
Comparable companies
Comparable drug discovery names by valuation on PrivateMarketView: Mythic Therapeutics ($293 million), City Therapeutics ($285 million) and Ensoma ($280 million).
How Convergent Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Convergent Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about Convergent Therapeutics
- What is Convergent Therapeutics worth?
- Convergent Therapeutics's last known valuation is $280.0M.
- How much has Convergent Therapeutics raised?
- Convergent Therapeutics has raised $130.0M in total funding across 2 recorded rounds.
- When did Convergent Therapeutics last raise?
- Convergent Therapeutics last raised in Jul 2024 (Early Stage VC), raising $22.2M.